About Courtagen
Courtagen is a company based in Woburn (United States) founded in 2009 by Brian McKernan. It operates as a B2B. Courtagen has raised $41.31 million across 6 funding rounds from investors including Adler & Co, Bunker Hill Capital and First Analysis. The company has 128 employees as of December 31, 2022. Courtagen has completed 1 acquisition, including Medicinal Genomics. Courtagen operates in a competitive market with competitors including Sunbird Bio, BrainSpec, Mursla, Neurovigil and Quadrant Biosciences, among others.
- Headquarter Woburn, United States
- Employees 128 as on 31 Dec, 2022
- Founders Brian McKernan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Courtagen Life Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41.31 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series C
Jun 12, 2015
-
Investors
Adler & Co.
& 3 more
-
Employee Count
128
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Courtagen
Courtagen has successfully raised a total of $41.31M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Courtagen
Courtagen has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Adler & Co, Bunker Hill Capital and First Analysis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term growth capital is invested in lower middle market companies.
|
Locked | Locked | Locked | |
|
Venture capital and transaction advisory services for B2B tech companies.
|
Locked | Locked | Locked | |
|
Tech & Life Science focused early stage VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for Courtagen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Courtagen
Courtagen has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medicinal Genomics.
Investment portfolio details for Courtagen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of cannabis sequencing services
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Courtagen
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Courtagen
Detailed financials for Courtagen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Courtagen Comparisons
Peer comparison for Courtagen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Courtagen
Courtagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sunbird Bio, BrainSpec, Mursla, Neurovigil and Quadrant Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| Locked | Locked | Locked |
Web-based MRS platform for brain metabolite analysis is utilized.
|
|
| Locked | Locked | Locked |
Diagnostic devices for cancer detection are developed using nanostructures.
|
|
| Locked | Locked | Locked |
Solution provider for analysis of brain data in medical applications
|
|
| Locked | Locked | Locked |
Technologies for the evaluation of brain health and autism spectrum disorders
|
Detailed competitors of Courtagen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Courtagen
Complete news archive for Courtagen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Courtagen
Courtagen was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Courtagen is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Brian McKernan is the current CEO of Courtagen. They have also founded this company.
Courtagen is a funded company, having raised a total of $41.31M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Courtagen is 128.
Courtagen, founded in 2009 in Woburn, United States, focuses on providing healthcare solutions, advancing biotech innovations, neurological and metabolic disorders, and therapeutic solutions. Provides solutions for neurological and metabolic disorders. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Courtagen's top competitors include Sunbird Bio, Mursla and SyntheticMR.
Courtagen has made 1 acquisition, including Medicinal Genomics.
Courtagen has 4 investors. Key investors include Adler & Co, Bunker Hill Capital, First Analysis, and Harbor Light Capital Partners.